The Singapore-based toolmaker and injection molder is scheduled to launch an initial public offering on the Singapore Exchange on July 10. Proceeds will help expand the Kunshan plant in China’s Jiangsu province, and Johor plant in southern Peninsular Malaysia.

JLJ said S$1.296 million (US$890,501 or 6.08 million yuan) will be used as a working capital.

JLJ also plans to transform the Singapore plant into a technical support hub and manufacturing center for niche products.

JLJ hopes to raise S$4.3 million (US$2.95 million or 20.19 million yuan) from the 19 million shares being offered. Executive Chairman and founder Jacky Chua is banking continued growth thanks to major customers, and he especially noted Apple Computer Inc.’s ongoing business performance.

“Given our well established relationship with Apple, we are well positioned to ride on the continued growth in tandem with the global demand for Apple products,” Chua said.

Other key markets include medical diagnostic devices and precision laboratory equipment.

Established in 1993, JLJ designs, fabricates and sells plastic injection molds, plus provides injection molding and value-added services.

The company’s customers in the consumer electronics, computer peripherals, automotives and household appliances industries are located in the United States, Europe and Malaysia.

JLJ’s sales improved slightly to S$50.83 million (US$34.93 million or 238.61 million yuan) in 2008 from S$49.01 million (US$33.68 million or 230.07 million yuan) in 2007. But 2008 net profit was lower at S$4.88 million (US$3.35 million or 22.91 million yuan), down from S$5.78 million (US$3.97 million or 27.15 million yuan) in 2007.